Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages
- PMID: 20622108
- PMCID: PMC2944489
- DOI: 10.1152/ajpheart.00115.2010
Adiponectin primes human monocytes into alternative anti-inflammatory M2 macrophages
Abstract
Altered macrophage kinetics is a pivotal mechanism of visceral obesity-induced inflammation and cardiometabolic risk. Because monocytes can differentiate into either proatherogenic M1 macrophages or anti-inflammatory M2 macrophages, approaches that limit M1 while promoting M2 differentiation represent a unique therapeutic strategy. We hypothesized that adiponectin may prime human monocytes toward the M2 phenotype. Adiponectin promoted the alternative activation of human monocytes into anti-inflammatory M2 macrophages as opposed to the classically activated M1 phenotype. Adiponectin-treated cells displayed increased M2 markers, including the mannose receptor (MR) and alternative macrophage activation-associated CC chemokine-1. Incubation of M1 macrophages with adiponectin-treated M2-derived culture supernatant resulted in a pronounced inhibition of tumor necrosis factor-alpha and monocyte chemotactic protein-1 secretion. Activation of human monocytes into M2 macrophages by adiponectin was mediated, in addition to AMP-activated protein kinase and peroxisome proliferator-activated receptor (PPAR)-gamma, via PPAR-alpha. Furthermore, macrophages isolated from adiponectin knockout mice demonstrated diminished levels of M2 markers such as MR, which were restored with adiponectin treatment. We report a novel immunoregulatory mechanism through which adiponectin primes human monocyte differentiation into anti-inflammatory M2 macrophages. Conditions associated with low adiponectin levels, such as visceral obesity and insulin resistance, may promote atherosclerosis, in part through aberrant macrophage kinetics.
Figures
Similar articles
-
Atorvastatin promotes human monocyte differentiation toward alternative M2 macrophages through p38 mitogen-activated protein kinase-dependent peroxisome proliferator-activated receptor γ activation.Int Immunopharmacol. 2015 May;26(1):58-64. doi: 10.1016/j.intimp.2015.03.005. Epub 2015 Mar 18. Int Immunopharmacol. 2015. PMID: 25794645
-
Rosiglitazone inhibits monocyte/macrophage adhesion through de novo adiponectin production in human monocytes.J Cell Biochem. 2010 Aug 15;110(6):1410-9. doi: 10.1002/jcb.22657. J Cell Biochem. 2010. PMID: 20506517
-
PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.Cell Metab. 2007 Aug;6(2):137-43. doi: 10.1016/j.cmet.2007.06.010. Cell Metab. 2007. PMID: 17681149
-
Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways.Cell Signal. 2014 Feb;26(2):192-7. doi: 10.1016/j.cellsig.2013.11.004. Epub 2013 Nov 9. Cell Signal. 2014. PMID: 24219909 Review.
-
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation.Front Immunol. 2014 Oct 17;5:514. doi: 10.3389/fimmu.2014.00514. eCollection 2014. Front Immunol. 2014. PMID: 25368618 Free PMC article. Review.
Cited by
-
Exercise, Neuroprotective Exerkines, and Parkinson's Disease: A Narrative Review.Biomolecules. 2024 Sep 30;14(10):1241. doi: 10.3390/biom14101241. Biomolecules. 2024. PMID: 39456173 Free PMC article. Review.
-
Lack of "immunological fitness" during fasting in metabolically challenged animals.J Lipid Res. 2012 Jul;53(7):1254-67. doi: 10.1194/jlr.M021725. Epub 2012 Apr 13. J Lipid Res. 2012. PMID: 22504909 Free PMC article.
-
Recombinant adiponectin protects the newborn rat lung from lipopolysaccharide-induced inflammatory injury.Physiol Rep. 2020 Sep;8(17):e14553. doi: 10.14814/phy2.14553. Physiol Rep. 2020. PMID: 32889775 Free PMC article.
-
Role of Leptin and Adiponectin in Carcinogenesis.Cancers (Basel). 2023 Aug 24;15(17):4250. doi: 10.3390/cancers15174250. Cancers (Basel). 2023. PMID: 37686525 Free PMC article. Review.
-
A decade of progress in adipose tissue macrophage biology.Immunol Rev. 2014 Nov;262(1):134-52. doi: 10.1111/imr.12216. Immunol Rev. 2014. PMID: 25319332 Free PMC article. Review.
References
-
- Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105: 2893–2898, 2002 - PubMed
-
- Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 6: 137–143, 2007 - PubMed
-
- Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285: E527–E533, 2003 - PubMed
-
- Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278: 45021–45026, 2003 - PubMed
-
- Chinetti G, Lestavel S, Fruchart JC, Clavey V, Staels B. Peroxisome proliferator-activated receptor alpha reduces cholesterol esterification in macrophages. Circ Res 92: 212–217, 2003 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials